CD274 and Miyoshi myopathy: Immune checkpoint proteins programmed cell death protein (PD-1) and programmed cell death 1 ligand 1 (PD-L1) were extensively investigated in MM in the past few years due to their potential as targets in immunotherapy [11,12,13].